Welcome to our dedicated page for HAPP news (Ticker: HAPP), a resource for investors and traders seeking the latest updates and insights on HAPP stock.
This page provides a historical news archive for Happiness Development Group Limited (HAPP) and its transition to Paranovus Entertainment Technology Ltd. Company press releases trace how HAPP evolved from a diversified business in nutraceutical and dietary supplements, e-commerce solutions and automobile sales into a renamed entity with a focus on entertainment and technology under the PAVS ticker.
Earlier news items under the HAPP symbol describe activities in its three main business lines, including developments in its nutraceutical and dietary supplement portfolio, initiatives in e-commerce services for small and medium-sized enterprises in China, and agreements related to automobile sales using a B2B model. These releases also cover corporate actions such as reverse share splits and Nasdaq notifications about minimum bid price compliance.
Later announcements under the Paranovus Entertainment Technology Ltd. name document the company’s strategic shift. They outline plans to enter a pan-entertainment field using technologies such as AI and describe a focus on AI-powered entertainment products, AI-driven games and applications, and TikTok-related e-commerce solutions through subsidiaries. Additional releases discuss the exit of legacy e-commerce, internet information, advertising and automobile sales businesses, as well as the acquisition of controlling equity interests in Bomie Wookoo Inc., a company offering e-commerce solutions.
Investors and researchers can use this news archive to follow the company’s corporate history, business transitions, and interactions with the Nasdaq Capital Market over time. For a complete view of the current business focus, more recent news under the PAVS symbol and Paranovus Entertainment Technology Ltd. name is particularly relevant.
Happiness Biotech Group Limited (HAPP) reported sales exceeding $5 million for its e-commerce subsidiary, Happy Buy, in January 2021, maintaining stability despite challenges from the COVID-19 epidemic and seasonal factors. CEO Xuezhu Wang highlighted an optimistic outlook, projecting sales between $8 million and $10 million for March, marking a potential increase of 60% to 100%. Additionally, the newly launched Happy Auto platform has secured over $5 million in potential orders, primarily in new energy vehicles, reinforcing the company's growth strategy.
Happiness Biotech Group Limited (HAPP) announced the official launch of its B2B auto sales platform, "Happy Auto," after a successful trial period that yielded approximately $1 million in sales over three months. Jointly established with local car dealers, Happy Auto aims to tackle overcapacity in China's automobile market by redistributing inventory to lower-tier cities. The CEO expressed confidence in the platform's growth, leveraging the experiences from their first successful venture, Happy Buy.
Happiness Biotech Group Limited (Nasdaq: HAPP) reported a 30.2% decrease in revenue to $21.88 million for the six months ended September 30, 2020, down from $31.36 million in the previous year. Operating income fell by 62.4% to $3.69 million, and net income dropped to $3.18 million from $8.42 million. The decline was attributed to the COVID-19 pandemic's impact on the retail market. Despite these challenges, the company launched its e-commerce business in September 2020 and aims for a revenue target of $70 million for the fiscal year ending March 31, 2021.
Happiness Biotech Group Limited (HAPP), a China-based nutraceutical producer, reported a significant milestone with its subsidiary, Happy Buy, achieving over 70% growth in December 2020 compared to November, totaling $5.5 million in sales. This growth is attributed to the team's efforts and newly attracted e-commerce investors. The Company also anticipates launching Happy Buy International by April 2021, expanding access to its products for overseas consumers. The company has a diverse portfolio of registered nutraceutical products in China.
Happiness Biotech Group Limited (Nasdaq: HAPP) has entered a securities purchase agreement for a registered direct placement with non-U.S. strategic investors, planning to issue up to 4.2 million ordinary shares. The expected gross proceeds from this offering could reach approximately $7 million based on current trading levels. Proceeds will support the growth of its subsidiary Happy Buy, focusing on social e-commerce and digital marketing. This transaction aims to enhance the company’s market position and capitalize on the e-commerce industry's potential.
Happiness Biotech Group Limited (HAPP) announced that its subsidiary, Happy Buy, has received an 80% tax rebate from the Shunchang County Government in Fujian Province, China. This incentive, which includes local value-added tax and corporate income tax, is part of a broader initiative to support technology industries. Happy Buy achieved e-commerce sales exceeding $3 million since November 2020, with expectations to reach $20 million by the fiscal year-end on March 31, 2021. The company aims to expand its operations significantly with this financial boost.
Happiness Biotech Group Limited (HAPP) announced its e-commerce subsidiary, Happy Buy, achieved over $3 million in sales since November 2020, just after its launch in September. Utilizing multiple sales channels, including live streaming and partnerships with influencers, Happy Buy has experienced consistent growth even post the '11.11' shopping festival. The company aims for $20 million in e-commerce sales by March 31, 2021. This rapid sales growth positions e-commerce as a vital part of Happiness Biotech's future strategy.
Happiness Biotech Group Limited (Nasdaq: HAPP) has launched Coenzyme Q10, a product sourced from Xiamen Kingdomway Group, in its 26 experience stores across China. Coenzyme Q10 is known for its potential health benefits, including aiding conditions such as diabetes and Alzheimer's. The CEO highlighted that this addition enhances market influence and sales performance while aiming to diversify the product range. Happiness Biotech, founded to produce high-quality nutraceuticals, currently holds 32 registered nutraceutical SKUs in China.
Happiness Biotech Group Limited (Nasdaq: HAPP) announced the registration of its hand sanitizer products with the U.S. Food and Drug Administration. This marks a significant milestone for the company, as it aims to contribute to public health efforts amid the pandemic. Previously, the hand sanitizer was granted a National Product Number license in Canada, where it has been exported. The CEO, Xuezhu Wang, expressed optimism about anticipated sales in the U.S. post-registration, highlighting the company’s commitment to high-quality nutraceutical products.
Happiness Biotech Group Limited (Nasdaq: HAPP) announced a securities purchase agreement to sell 900,000 ordinary shares at $2.50 each, totaling $2.25 million. The proceeds will support the development of Happy Buy's B2B e-commerce segment and serve as working capital. CEO Xuezhu Wang expressed confidence in the strategic investors' ability to bolster Happy Buy's growth, leveraging their resources and business connections.